Melanoma Clinical Trials in Denver

Showing 161-180 of 288 trials

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

NCT00130442

The aim of the study is to compare the safety and effectiveness of a new drug called PI-88, when used in combination with an approved chemotherapy drug called dacarbazine, in the treatment of metastatic melanoma. PI-88 blocks new blood vessel growth in tumours (starves it of nutrients) and dacarbazine stops the cancer cells from growing. The results from this study will be analysed to see if it is worthwhile for the two drugs to be tested in future studies involving larger numbers of melanoma patients.

Melanoma

Cellxpert Biotechnology Corp.134 participantsStarted Jun 2005

Tucson, Arizona, United States • Denver, Colorado, United States • Nashville, Tennessee, United States +9 more locations

COMPLETEDPhase 1/28.4 miles

Study of PI-88 in Patients With Advanced Melanoma

NCT00068172

The purpose of this study is to determine whether PI-88 is safe and effective in the treatment of advanced melanoma.

Melanoma

Cellxpert Biotechnology Corp.88 participantsStarted Jul 2001

Aurora, Colorado, United States

COMPLETEDPhase 38.4 miles

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

NCT02714218

The purpose of this study is to evaluate two different dose combinations of nivolumab and ipilimumab in the treatment of melanoma.

Melanoma

Bristol-Myers Squibb387 participantsStarted Apr 2016

Aurora, Colorado, United States • Tampa, Florida, United States • Fridley, Minnesota, United States +54 more locations

Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma

Study of PI-88 in Patients With Advanced Melanoma

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

Melanoma Trials in Other Cities

A Study Comparing Vemurafenib Versus Vemurafenib Plus Cobimetinib in Participants With Metastatic Melanoma

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

Virtual Sun Safe Workplaces Ph I

Engaging Moms on Teen Indoor Tanning Through Social Media

Multicenter Selective Lymphadenectomy Trial II (MSLT-II)

Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

Pembrolizumab With Talimogene Laherparepvec or Placebo in Unresected Melanoma

A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Ipilimumab and Nivolumab as Adjuvant Treatment of Mucosal Melanoma

A Study of ADXS-NEO Expressing Personalized Tumor Antigens

This SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.

A Study of PLX2853 in Advanced Malignancies.

A Study of Cobimetinib Plus Atezolizumab Versus Pembrolizumab in Participants With Previously Untreated Advanced BRAFv600 Wild-Type Melanoma

Safety Study of Enoblituzumab (MGA271) in Combination With Ipilimumab in Refractory Cancer

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Other Conditions in Denver